In this episode, Suzanne Spradley and Chase Cannon revisit the history and importance of the tax exclusion for employer-sponsored insurance (ESI) coverage. Suzanne takes us back to the 1940s to understand how the tax exclusion began. The two discuss the reasons for the longevity and stability of the ESI model and how it has impacted the accessibility and affordability of health insurance in the U.S. Suzanne closes by addressing a new U.S. Congressional proposal that could impact employers and the ESI model.

In this episode, Chase Cannon and Suzanne Spradley look at some common blind spots that employers, as plan sponsors, should review with respect to compliance. Chase outlines the first two blind spots that relate to the application of COBRA and COBRA initial notice distribution. Chase and Suzanne then discuss how employee counts can trip up employers when it comes to how certain compliance laws apply. The two close the podcast with a discussion of the impact of remote employees on state paid family and medical leave requirements.

In this episode, Suzanne Spradley and Chase Cannon discuss two recent circuit court decisions and their impact on employer-sponsored group health plans. Suzanne first discusses a Sixth Circuit decision involving a state law that attempts to regulate PBMs. Suzanne and Chase walk through Supreme Court precedent that appears to be driving states to enact PBM laws, and they explain how ERISA preemption is at the heart of it all. Suzanne concludes the podcast by outlining another federal decision relating to a fiduciary breach claim of an employer group health plan.

In this episode, Chase Cannon and Suzanne Spradley review three important upcoming compliance-related deadlines. Chase highlights the three requirements, including ACA reporting, an April 15 deadline related to HSA contributions and distributions, and RxDC reporting. Chase and Suzanne discuss some practical approaches to each of those deadlines and conclude with a summary of how recent DOL enforcement priorities and ERISA fiduciary litigation come into play.

In this episode, Suzanne Spradley and Chase Cannon review the outlook of health policy in the current Washington, DC environment. Suzanne leads off, setting the stage with a description of the narrow House Republican majority and its impact on enacting legislation. Suzanne and Chase discuss several pieces of legislation focused on transparency, including site-neutral payment reform and drug pricing. The two address regulatory activity that potentially targets PBMs and No Surprises Act issues. The episode concludes with a discussion of legislative and regulatory impact on employer group health plans.

In this episode, Chase Cannon and Suzanne Spradley review a recent DOL announcement that outlines the agency’s enforcement priorities for group health plans. Chase provides some background on DOL enforcement and the DOL’s efforts to increase employee benefit plan compliance, address abusive practices, and protect the rights of participants and beneficiaries. Chase and Suzanne go deeper on four of the priorities, including mental health parity, cybersecurity, abuse of contributory benefit plans, and surprise billing, including important takeaways for employers to consider going forward.

In this episode, Chase Cannon and Suzanne Spradley discuss a recent wave of litigation centered on ERISA’s fiduciary obligations for health and welfare plan sponsors. Suzanne begins with an explanation of the lawsuits and how the voluntary benefit plan exception from ERISA is core to the lawsuit allegations. Suzanne and Chase continue with a close look at the exception and the criteria employers should consider to meet the exception. The two close with a discussion on employer takeaways for ERISA fiduciary and voluntary plan exception purposes.

In this episode, Chase Cannon and Suzanne Spradley discuss recently released guidance on fertility benefits. Chase provides the background on how employers might be able to offer fertility benefits as “excepted” or “independent, non-coordinated" benefits, which may ease some compliance burdens. Suzanne and Chase discuss the cost aspects of fertility benefits and how an excepted benefit Health Reimbursement Arrangement could potentially help provide a benefit vehicle for employers. The two finish the episode talking about how employers should stay tuned for additional guidance on developing a compliant fertility benefit plan offering.

In this episode, Chase Cannon and Suzanne Spradley discuss recent and noteworthy guidance from the IRS despite the federal government shutdown. Chase and Suzanne dive into the recently announced IRS inflation-adjusted amounts for benefits-related items in 2026 and their impact on employer plans. The podcast winds down with a discussion on what employers should consider and a preview of the next podcast topic: fertility benefits.

In this episode, Suzanne Spradley and Chase Cannon discuss a September 2025 presidential announcement regarding tariffs on pharmaceutical products. Suzanne provides some background on the announcement and what it might mean for the U.S. and other countries. Suzanne and Chase explore the potential benefits and drawbacks of a new website relating to prescription drugs. Suzanne closes the podcast by outlining the potential impact on employer-sponsored group health plans and drug plans.